Identification of class II transcriptional activator-induced genes by representational difference analysis: Discoordinate regulation of the DNα/DOβ heterodimer

Journal of Immunology

Volumn 165, Issue 3, 2000, Pages 1410-1416

  Taxman, Debra J ^b   Cressman, Drew E ^b   Ting, Jenny P Y ^a,b  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CELL COMPARTMENTALIZATION; ENDOPLASMIC RETICULUM; FIBROSARCOMA; GENETIC ANALYSIS; GENETIC REGULATION; INTERNALIZATION; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PURIFICATION; TRANSCRIPTION REGULATION;

EID: 0034254648     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.3.1410     Document Type: Article

References (59)

1. Kvist, S., K. Wiman, L. Claesson, P. A. Peterson, and B. Dobberstein. 1982. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell 29:61.
2. Tulp, A., D. Verwoerd, B. Dobberstein, H. L. Ploegh, and J. Pleters. 1994. Isolation and characterization of the intracellular MHC class II compartment. Nature 369:120.
3. Bakke, O., and B. Dobberstein. 1990. MHC class II associated invariant chain contains a sorting signal for endocytic compartments. Cell 63:707.
4. Lotteau, V., L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S. Schmid, V. Quaranta, and P. A. Peterson. 1990. Intracellular transport of class II MHC molecules directed by the invariant chain. Nature 348:600.
5. Roche, P. A., and P. Cresswell. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345:615.
6. Fling, S. P., B. Arp, and D. Pious. 1994. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368:554.
7. Morris, P., J. Shaman, M. Attaya, M. Amaya, S. Goodman, C. Bergman, J. J. Monaco, and E. Mellins. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551.
8. Sanderson, F., M. J. Kleijmeer, A. Kelly, D. Verwoerd, A. Tulp, J. J. Neefjes, H. J. Geuze, and J. Trowsdale. 1994. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266:1566.
9. Cresswell, P. 1994. Antigen presentation: getting peptides into MHC class II molecules. Curr. Biol. 4:541.
10. Fung-Leung, W.-P., C. D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P. A. Peterson, S. R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science 271:1278.
11. Jensen, P. E., D. A. Weber, W. P. Thayer, L. E. Westerman, and C. T. Dao. 1999. Peptide exchange in MHC molecules. Immunol. Rev. 172:229.
12. Tonnelle, C., R. DeMars, and E. O. Long. 1985. DOβ: a new β chain gene in HLA-D with a distinct regulation of expression. EMBO J. 4:2839.
13. Liljedahl, M., T. Kuwana, W. P. Fung-Leung, M. R. Jackson, P. A. Peterson, and L. Karlsson. 1996. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J. 15:4817.
14. Kropshofer, H., A. B. Vogt, C. Thery, E. A. Armandola, B. C. Li, G. Moldenhauer, S. Amigorena, and G. J. Hammerling. 1998. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J. 17:2971.
15. Douek, D. C., and D. M. Allmann. 1997. HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int. Immunol. 9:355.
16. Denzin, L. K., D. B. Sant'Angelo, C. Hammond, M. J. Surman, and P. Cresswell. 1997. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278:106.
17. van Ham, S. M., E. P. M. Tjin, B. F. Lillemeier, U. Gruneberg, K. E. van Meijgaarden, L. Pastoors, D. Venvoerd, A. Tulp, B. Canas, D. Rahman, et al. 1997. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr. Biol. 7:950.
18. Liljedahl, M., O. Winqvist, C. D. Surh, P. Wong, K. Ngo, L. Teyton, P. A. Peterson, A. Brunmark, A. Y. Rudensky, W. P. Fung-Leung, and L. Karlsson. 1998. Altered antigen presentation in mice lacking H2-O. Immunity. 8:233.
19. Jensen, P. E. 1998. Antigen processing: HLA-DO - a hitchhiking inhibitor of HLA-DM. Curr. Biol. 8:R128.
20. Kropshofer, H., G. J. Hammerling, and A. B. Vogt. 1999. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules. Immunol. Rev. 172:267.
21. Alfonso, C., M. Liljedahl, O. Winqvist, C. D. Surh, P. A. Peterson, W. P. Fung-Leung, and L. Karlsson. 1999. The role of H2-O and HLA-DO in major histocompatibility complex class II-restricted antigen processing and presentation. Immunol. Rev. 172:255.
22. Steimle, V., B. Durand, E. Barras, M. Zufferey, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021.
23. Durand. B., P. Sperisen, P. Emery, E. Barras, M. Zufferey, B. Mach, and W. Reith. 1997. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16:1045.
24. Masternak, K., E. Barras, M. Zufferey, B. Conrad, G. Corthals, R. Aebersold, J. C. Sanchez, D. F. Hochstrasser, B. Mach, and W. Reith. 1998. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20:273.
25. Nagarajan, U. M., P. Louis-Plence, A. DeSandro, R. Nilsen, A. Bushey, and J. M. Boss. 1999. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10:153.
26. Reith, W., S. Satola, C. H. Sanchez, I. Amaldi, B. Lisowska-Grospierre, C. Griscelli, M. R. Hadam, and B. Mach. 1988. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein. RF-X. Cell 53:897.
27. Jabrane-Ferrat, N., J. D. Fontes, J. M. Boss, and B. M. Peterlin. 1996. Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions. Mol. Cell Biol. 16:4683.
28. Steimle, V.. L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
29. Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106.
30. Chin, K.-C., C. Mao, C. Skinner, J. L. Riley, K. L. Wright, C. S. Moreno, G. R. Stark, J. M. Boss, and J. P.-Y. Ting. 1994. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1:687.
31. Chang, C. H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
32. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533.
33. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
34. Kretsovali, A. T. Agalioti, C. Spilianakas, E. Tzortzakaki, M. Merika, and J. Papamatheakis. 1998. Involvement of CREB binding protein in expression of major histocompatihilily complex class II genes via interaction with the class II transactivator. Mol. Cell Biol. 18:6777.
35. Chin, K.-C., G. X. Li, and J. P.-Y. Ting. 1997. Importance of acidic, proline/ serine/threonine-rich, and GTP-binding regions in the major histocompalibility complex class II transactivator: generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. USA 94:2501.
36. Cressman, D. E., K. C. Chin, D. J. Taxman, and J. P. Ting. 1999. A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome. Immunity, 10:163.
37. Brown, J. A., E. M. Rogers, and J. M. Boss. 1998. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element. Nucleic Acids Res. 26:4128.
38. Fontes, J. D., N. Jabrane-Ferrat, C. R. Toth, and B. M. Peterlin. 1996. Binding and cooperative interactions between two B cell-specific transcriptional coactivators. J. Exp. Med. 183:2517.
39. Fontes, J. D., B. Jiang, and B. M. Peterlin. 1997. The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32. Nucleic Acids Res. 25:2522.
40. Scholl, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific complex formation between the type II bare lymphocyte syndrom-associated transactivators CIITA and RFX5. Proc. Natl Acad. Sci. USA 94:6330.
41. Moreno, C. S., G. W. Beresford, P. Louis-Plence, A. C. Morris, and J. M. Boss. 1999. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10:143.
42. Fontes, J. D., S. Kanazawa, D. Jean, and B. M. Peterlin. 1999. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol. Cell Biol. 19:941.
43. Harton, J. A., D. E. Cressman, K. C. Chin, C. J. Der, and J. P. Ting. 1999. GTP binding by class II transactivator: role in nuclear impart. Science 285:1402.
44. Chang, C.-H., S. Guerder, S.-C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167.
45. Lisitsyn, N., and M. Wigler. 1993. Cloning the differences between two complex genomes. Science 259:946.
46. Hubank, M., and D. G. Schatz. 1994. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 22:5640.
47. Lisitsyn, N., and M. Wigler. 1995. Representational difference analysis in detection of genetic lesions in cancer. Methods Enzymol. 254:291.
48. Hubank, M., and D. G. Schatz. 1999. cDNA representational difference analysis: a sensitive and flexible method for identification of differentially expressed genes. Methods Enzymol. 303:325.
49. Mao, C., D. Davies, I. M. Kerr, and G. R. Stark. 1993. Mutant human cells defective in induction of major histocompatibility complex class II genes by interferon gamma. Proc. Natl. Acad. Sci. USA 90:2880.
50. Wright, K. L., K.-C. Chin, M. Linhoff, C. Skinner, J. A. Brown, J. M. Boss, G. R. Stark, and J. P.-Y. Ting. 1998. CIITA stimulation of transcription factor binding to MHC class II and associated promoters in vivo. Proc. Natl. Acad. Sci. USA 95:6267.
51. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
52. Rosen-Bronson, S., and E. O. Long. 1991. An unusual form of alternative splicing in the HLA-DNA gene. Immunogen 33:124.
53. Young, J. A., and J. Trowsdale. 1990. The HLA-DNA (DZA) gene is correctly expressed as a 1.1 kb mature mRNA transcript. Immunogen 31:386.
54. Voliva, C. F., S. Tsang, and B. M. Peterlin. 1993. Mapping cis-acting defects in promoters of transcriptionally silent DQA2, DQB2, and DOB genes. Proc. Natl. Acad. Sci. USA 90:3408.
55. Ponzoni, M., F. Guarnaccia, M. V. Corrias, and P. Cornaglia-Ferraris. 1993. Uncoordinate induction and differential regulation of HLA class-I and class-II expression by γ-interferon in differentiating human neuroblastoma cells. Int. J. Cancer 55:817.
56. Kelly, A., and J. Trowsdale. 1985. Complete nucleotide sequence of a functional HLA-DPβ gene and the region between the DPβ1 and DPα1 genes: comparison of the 5′ ends of HLA class II genes. Nucleic Acids Res. 13:1607.
57. Kelly, A. P., J. J. Monaco, S. G. Cho, and J. Trowsdale. 1991. A new human HLA class II-related locus, DM. Nature 353:571.
58. Zhu, X.-S., M. W. Linhoff, G. Li, K.-C. Chin, S. N. Maity, and J. P.-Y. Ting. A transcriptional scaffold: CIITA interacts with NF-Y, RFX and CREB to cause stereospecific regulation of the class II MHC promoter. Mol. Cell Biol. In press.
59. Kanazawa, S., T. Okamoto, and B. M. Peterlin. 2000. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 12:61.